Key facts
- It has raised $3.3M; the latest was Seed Round ($3.3M) in Oct 2025.
- Notable investors include Designer Fund, Max Ventures, Red Swan Ventures, CoFound Partners, Humbition.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Previvor Edge
- ·The full record, as it builds
Funding rounds
No funding rounds for Previvor Edge are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Previvor Edge
Provider of a physician-led clinical program intended to personalize cancer prevention and early detection. The company focuses on delivering personalized cancer prevention and early detection to anyone who wants to understand the risk and take science-backed action, enabling people in cancer early detection with less treatment, better outcomes and lower costs.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2024
- Website
- previvoredge.com/
- Ownership
- Privately Held (backing)
Previvor Edge doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Previvor Edge shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Previvor Edge in its N-PORT filings yet. We sweep new filings monthly.